Atulya Agarwal

Atulya has over 30 years of executive and leadership experience in the biotechnology industry and serves as Inscripta’s Chief Legal Officer. Prior to Inscripta, Atulya held positions at PACT Pharma as its Chief Legal and Business Strategy Officer; Genentech as its Head of IP Licensing and Business Strategy; and Elan Pharmaceuticals as its Chief Intellectual Property Officer. Atulya also previously served as a law partner at Dickstein Shapiro LLP.

Atulya received a J.D. from Santa Clara University School of Law, a Ph.D. in Biochemistry from Boston University School of Medicine and a B.S. in Biochemistry from The Pennsylvania State University.